drugset / Trial / NCT00304655
Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to prove safety and efficacy of aripiprazole.
Timeline
- Start
- 2004-07
- Primary completion
- 2006-05
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 10 mg | — |
| Subject | Aripiprazole | Other / unclassified | 15 mg | — |
| Subject | Aripiprazole | Other / unclassified | 30 mg | — |